Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 38 of 100
Newsletters
Coronavirus interruption of drug supply chain pushes Sanofi to open a firm in France
By
Sy Mukherjee
February 24, 2020
Health
Sanofi is set to launch a new European drug manufacturing firm
By
Sy Mukherjee
February 24, 2020
Health
China’s high smoking rate may be exacerbating the coronavirus outbreak
By
Sy Mukherjee
February 19, 2020
Health
SARS treatments could help with the new coronavirus. Why were they shelved?
By
Sy Mukherjee
February 18, 2020
Magazine
Business gets ready to trip: How psychedelic drugs may revolutionize mental health care
By
Jeffrey M. O'Brien
February 17, 2020
Health
AstraZeneca stock slips on mixed earnings report and coronavirus uncertainty
By
Sy Mukherjee
February 14, 2020
Magazine
‘Miracle’ cancer treatments could be a blessing for investors too
By
Ryan Derousseau
February 13, 2020
Commentary
How this gene therapy drug earned its $2.1 million price tag
By
Sally C. Pipes
February 7, 2020
Newsletters
First step in study shows CRISPR gene-edited cells are safe for use in cancer patients
By
Sy Mukherjee
February 6, 2020
Tech
Startup uses A.I. to identify molecules that could fight coronavirus
By
Jeremy Kahn
February 6, 2020
Newsletters
Nestlé invests another $200 million in Aimmune’s peanut allergy drug
By
Sy Mukherjee
February 6, 2020
Health
Walgreens will pay $7.5 million over phony pharmacist who filled 750,000 prescriptions
By
The Associated Press
February 4, 2020
Newsletters
A vaccine that looked promising for HIV doesn’t work
By
Sy Mukherjee
February 4, 2020
Health
The first coronavirus drug candidate is set for testing in China
By
Sy Mukherjee
February 3, 2020
Health
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
By
Sy Mukherjee
February 2, 2020
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez